SCHEMBL24945812

SCHEMBL24945812

CC(C)(C)c1c(O)cc(Cl)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
TSHR P16473 6/20 0.50
HSD17B10 Q99714 6/20 0.50
HPGD P15428 4/20 0.50
CYP3A4 P08684 3/20 0.44
RECQL P46063 2/20 0.44
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ALOX15 P16050 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP1A2 P05177 1/20 0.37
ATP2A2 P16615 1/20 0.37
ATP2A3 Q93084 1/20 0.37
ACLY P53396 1/20 0.37
NR1I2 O75469 2/20 0.35
LMNA P02545 2/20 0.35
TTR P02766 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9742214 0.88 ALDH1A1 (0.44) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL12251273 0.83 ALDH1A1 (0.45) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL13167790 0.74 RAPGEF4 (0.41) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL24425171 0.74 ALDH1A1 (0.36) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL11215289 0.73 HSD17B10 (0.43) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL10936836 0.73 HSD17B10 (0.50) ALDH1A1HSD17B10HPGDCYP3A4CA1
SCHEMBL25008862 0.73 HSD17B10 (0.52) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL7779210 0.71 TSHR (0.42) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL23542368 0.71 HSD17B10 (0.39) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL5848266 0.71 AKR1C2 (0.55) ALDH1A1TSHRHSD17B10HPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNA3, KCNH2, KCNJ2 ALDH1A1 1910/4885TSHR 1706/4885HSD17B10 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.